Johnson & Johnson’s (JNJ -0.9%) newfound dominance of the orthopedic device market from its...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Johnson’s (JNJ -0.9%) newfound dominance of the orthopedic device market from its $21.3B acquisition of Synthes may pressure rivals Zimmer (ZMH +3.3%) and Stryker (SYK +0.2%) to seek purchases of their own among smaller ortho companies. Potential targets: ARTC, BMTI, WMGI.